94576 ⎘
Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings 1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
Radioiodination method
#302TRIAZOLIDE BASED IONIC LIQUIDS
#303Synthesis, structure and use of functionalized naphthalenes
#304Glucagon receptor modulators
#305Azole compounds used as tuberculostatic and leishmanicide agents
#306(1,2,3-triazolyl)sulfonyl derivatives
#307Compounds and methods for treating candidiasis and aspergillus infections
#308Crystalline 1H-1,2,3-triazol-5-ylidenes
#309Process for preparation of rufinamide
#310TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF METASTATIC BONE DISEASE
#311COMPOUNDS AND METHODS FOR MODULATING G PROTEIN-COUPLED RECEPTORS
#312Lysophosphatidic acid receptor antagonists
#3131, 2, 4-triazole derivatives and their anti mycobacterial activity
#314COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT
#315Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#316Bifunctional histone deacetylase inhibitors
#317Insecticidal compounds
#318Heterocyclic CETP inhibitors
#319Halogen-free flame retarding materials based on bisphenol triazole resins and polymers
#320Proteostasis regulators
#321Chemical compounds capable of complexing at least one metal element and a coordination complex based on these compounds
#322Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
#323IRE-1α inhibitors
#324Inhibitors of sphingosine kinase
#325N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl) arylsulfonamides
#326Piperazine analogs as broad-spectrum influenza antivirals
#327Iodine radiolabelling method
#328FXR (NR1H4) binding and activity modulating compounds
#329Glucagon receptor modulators
#330Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
#331Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
#332Copper-catalysed ligation of azides and acetylenes
#333Tryptophan hydroxylase inhibitors
#334Copper catalyzed cycloaddition of organic azides and 1-haloalkynes
#3354- and 5 substituted 1,2,3-triazole moieties with at least one remote polymerizable moiety and polymers thereof
#336Benzamides and nicotinamides as Syk modulators
#337Substituted Esters as Cannabinoid-1 Receptor Modulators
#338Compounds, Compositions and Methods for Modulating Uric Acid Levels
#339F-labeled azide compound, reagent for F-labeling and method for F-labeling of alkyne compound using same
#340HISTONE DEACETYLASE INHIBITORS
#341Compounds and methods for treating mammalian gastrointestinal microbial infections
#342PHARMACEUTICAL PRODUCT
#343Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
#344Compounds for the treatment of proliferative disorders
#345MIF modulators
#346Cyclohexane derivative having NPY Y5 receptor antagonism
#3471,2,4-triazole derivatives as sigma receptor inhibitors
#348Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators
#349Hepatitis C virus inhibitors
#3501H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy
#3511,2,3-triazole based metal-organic framework as photo-active materials
#352Triazoles as inhibitors of fatty acid synthase
#353Azole compounds used as tuberculostatic and leishmanicide agents
#354Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists
#355NOVEL DIPHENYL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
#356Inhibitors of the Shiga toxins trafficking through the retrograde pathway
#357Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide
#358CXCR2 inhibitors
#359Compounds and methods for modulating G protein-coupled receptors
#360DIARYL-SUBSTITUTED FIVE-MEMBERED HETEROCYCLE DERIVATIVE
#361Heterocyclic amide compounds useful as kinase inhibitors
#3627-pyrazolyl tetracycline compounds and methods of use thereof
#363DIPHENYL-HETEROARYL DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES
#364Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#365Surfactant-enabled transition metal-catalyzed chemistry
#366Compounds as antagonists or inverse agonists at opioid receptors
#367IDO INHIBITORS AND THERAPEUTIC USES THEREOF
#368UV-absorbers for ophthalmic lens materials
#369Copper-catalysed ligation of azides and acetylenes
#370Therapeutic agent for Alzheimer's disease
#371TRIAZOLE AMIDE DERIVATIVES FOR USE IN THERAPY
#372NOVEL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
#373Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
#374FUNGICIDAL SUBSTITUTED AZOLES
#375CCR10 antagonists
#376N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl)hetaryl arylsulfonamides
#377Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry
#378Cyclopentane derivatives
#379VIRAL POLYMERASE INHIBITORS
#380Multicyclic amino acid derivatives and methods of their use
#381Halogen alkoxy spirocyclic tetramic and tetronic acid derivatives
#382COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
#383Non-Invasive Molecular Imaging of Cellular Histone Deacetylase Substrate Using Magnetic Resonance Spectroscopy (MRS) or Positron Emission Tomography (PET)
#384Heterocyclic CETP inhibitors
#3851,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
#386ARYL GPR120 RECEPTOR AGONISTS AND USES THEREOF
#387Process for producing purified synthesis gas from synthesis gas comprising trace amounts of sulphur contaminants with a metal-organic framework
#388Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
#389AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-ALPHA
#390Dipeptide analogs as coagulation factor inhibitors
#391Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#392Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#393NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
#394Phenylalkyl substituted heteroaryl derivatives
#395Niacin receptor agonists, compositions containing such compounds and methods of treatment
#396N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-quinazolin-3-yl)methanesulfonamide
#3971, 2, 3-triazole derivatives as new cannabinoid-1 receptor antagonists
#398Inhibitors of Akt activity
#399Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
#400Substituted benzene fungicides
#401UREA TYPE CINNAMIDE DERIVATIVE
#402MODULATORS OF PPAR AND METHODS OF THEIR PREPARATION
#403Process for preparing five-membered heterocyclyl tetracycline compounds and methods of use thereof
#404CHEMICAL COMPOUNDS
#4051,2,3-triazole derivatives as sigma receptor inhibitors
#4061,2,4-triazole derivatives as sigma receptor inhibitors
#407Iron-copper co-catalyzed process for carbon-carbon or carbon-heteroatom bonding
#408Bifunctional histone deacetylase inhibitors
#409Substituted hydroxyethylamine aspartyl protease inhibitors
#410Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
#411Inhibitors of histone deacetylase
#412COMPOSITIONS AND METHODS FOR COUPLING A PLURALITY OF COMPOUNDS TO A SCAFFOLD
#413Functionalized (meth)acrylic monomers and polymers for acetylenic alcohols
#414Triazole-substituted arylamides as P2Xand P2Xantagonists
#415Fungicide N-cyclopropyl-sulfonylamide derivatives
#416Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry
#417Diacylglycerol acyltransferase inhibitors
#418Triazole derivative and use thereof
#419Compounds and methods for modulating FXR
#420CYCLOADDITION OF AZIDES AND ALKYNES
#421Novel therapeutic compounds
#422Pharmaceutical Product
#423AZOLE COMPOUNDS USED AS TUBERCULOSTATIC AND LEISHMANICIDE AGENTS
#424Ophthalmic lens materials containing chromophores that absorb both UV and short wavelength visible light
#425Ophthalmic lens materials containing chromophores that absorb both UV and short wavelength visible light
#426Tetrazine-based bio-orthogonal coupling reagents and methods
#427Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
#428Antibacterial agents
#429N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
#430Arylsulfonamido-substituted hydroxamic acid derivatives
#431UV-absorbers for ophthalmic lens materials
#432Amidopropoxyphenyl Orexin Receptor Antagonists
#433Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
#434Copper-catalysed ligation of azides and acetylenes
#435Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
#436TETRAHYDRONAPHTHALENYLAMIDES, A PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
#437α-Amino-N-hydroxy-acetamide derivatives
#438Heterocyclic amide compounds useful as kinase inhibitors
#439Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands
#440Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
#441Inhibitors of histone deacetylase
#442SUBSTITUTED TRIAZOLES AS MODULATORS OF PPAR AND METHODS OF THEIR PREPARATION
#443C-kit modulators and methods of use
#444CXCR2 inhibitors
#445DIPEPTIDE NITRILES
#446Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
#447Arylsulfonylnaphthalene derivatives as 5HTantagonists
#448Piperazine and piperidine biaryl derivatives
#4491,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease
#450Compounds for the treatment of proliferative disorders
#451N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
#452Biaryl derivatives
#453Multicyclic amino acid derivatives and methods of their use
#454Triazole compounds and their use as metabotropic glutamate receptor antagonists
#455Diaryl-substituted five-membered heterocycle derivative
#456Compounds for the treatment of inflammatory disorders and microbial diseases
#457Heterocyclic CETP inhibitors
#458Heteroaryl substituted cyclohexyl-1,4-diamine compounds
#459Azo compound, aqueous dye solutions containing the same, inks and use thereof
#460P2Xreceptor antagonists and methods of use
#461Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#462Aralkyl amines as cannabinoid receptor modulators
#463Pyrazole derivative as PPAR modulator
#464Cytokine inhibitors
#465HIV reverse transcriptase inhibitors
#466Compositions and methods for coupling a plurality of compounds to a scaffold
#467Niacin receptor agonists, compositions containing such compounds and methods of treatment
#468α-amino-N-hydroxy-acetamide derivatives
#469Heterocyclic ppar modulators
#470Dipeptide nitriles
#471Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
#472Aminobenzophenone compounds
#473Tachykinin receptor antagonists
#474Triazole substituted aminobenzophenone compounds
#475Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
#476Five-membered heterocyclyl tetracycline compounds and methods of use thereof
#477Hexafluoroisopropanol substituted ether derivatives
#478Modulators of PPAR and methods of their preparation
#479Styrene polymers and phenol-triazole type complexes, catalysts, and processes for polymerizing
#480Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
#481Triazole compounds and their use as metabotropic glutamate receptor antagonists
#482Substituted aryl thioureas and related compounds; inhibitors of viral replication
#483Substituted triazoles as modulators of PPAR and methods of their preparation
#484Organic light emitting materials and devices
#485Triazole-derived kinase inhibitors and uses thereof
#486Compounds which inhibit leukocyte adhesion mediated by VLA-4
#487Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
#488Substituted hydroxyethylamine aspartyl protease inhibitors
#489Triazole derivatives as tachykinin receptor antagonists
#490Tachykinin receptor antagonists
#491Copper-catalysed ligation of azides and acetylenes
#492Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them
#493Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#494Alpha substituted carboxylic acids
#495Triazole compounds
#496Compounds and methods
#497Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
#498Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them
#499Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
#500Stabilised insulin compositions
#501Benzamide derivatives as antagonists of orexin receptors
#502Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase
#503Triazole inhibitors of type 2 methionine aminopeptidase
#504Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancer
#505Calpain modulators and therapeutic uses thereof
#506Small molecule modulators of IL-17
#507Synthesis and polymerization of vinyl triazolium ionic liquids
#508Synthesis of 4-(pentafluorosulfanyl)benzenediazonium tetrafluoroborate and analogs and their application for the preparation of SF-aromatics